A global pharmaceutical company focused on generic drugs, branded generics, and biosimilars across major therapeutic categories. The business was formed through the combination of Mylan and Pfizer’s Upjohn division and operates a large international portfolio of off‑patent medicines. Investors monit...
1 member of Congress has disclosed 2 trades in Viatris Inc. - Common Stock When (VTRSV), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-06-21 | Christopher L. Jacobs | buy | $1K – $15K |
| 2022-06-16 | Christopher L. Jacobs | buy | $15K – $50K |